Bandhan Healthcare Fund

Sectoral / ThematicEquityVery High risk

NAV · Direct-Growth

₹11.34+0.03+0.24%

As of 18 Aug 2026 · AMFI

NAV growth+13.8%

20252026

Arthkar verdictA balanced read

Cost

Average

0.74% vs NaN% peers

1Y return

—

3Y CAGR

—

5Y CAGR

—

AUM

₹310.92 Cr

fund size

Expense

0.74%

direct plan

Volatility 3Y

—

3Y std dev

In plain English

Bandhan Healthcare Fund is a Sectoral / Thematic scheme from Bandhan. The portfolio is ~96% in equities. Wrong fit if you need this money in less than 7 years.

Auto-generated from holdings, returns and risk data. No paid placement, no copy-pasted boilerplate.

NAV history

Showing Direct · Growth · INF194KB1KF5

NAV (Direct-Growth)

₹11.3360

Last 1Y

+13.84%

Dec 25Min ₹9.10 · Max ₹11.43 · 179 ptsAug 26

Honesty score

A 1–5 grade on the dimensions other sites won't surface — expense bloat, AUM bloat, concentration, mandate compliance.

Honesty score

4 / 5

Solid scheme on the dimensions we check. No red flags.

Expense ratio
0.74% — typical for category.
AUM size
₹311 Cr.
Sector concentration
Top 3 sectors = 95.9% — heavy concentration risk.

Computed from expense ratio, AUM, sector concentration and SEBI mandate compliance. No paid review.

Performance

Returns for various periods, with category average and peer rank.

Period	Returns	Category avg	Rank
1W	-0.86%	-0.40%	206/ 286
1M	+3.37%	+2.47%	106/ 286
3M	+9.03%	+8.01%	103/ 286
6M	+17.39%	+6.33%	36/ 278
YTD	+15.66%	+6.03%	46/ 273

Portfolio composition

Asset allocation

Equity96.27%
Cash3.73%

By market cap

Large cap41.87%
Mid cap22.33%
Others35.80%

Concentration

Holdings

Avg market cap

₹58.5K Cr

Top 10 stocks

59.05%

Top 5 stocks

39.30%

Top 3 sectors

95.87%

Top holdings

Top 15 positions by weight, latest disclosure.

#InstrumentSectorWeight

1
Sun Pharmaceuticals Industries Ltd
—9.65%
1
Sun Pharmaceuticals Industries Ltd
—9.34%
2
Apollo Hospitals Enterprise Ltd
—8.97%
2
Apollo Hospitals Enterprise Ltd
—8.67%
3
Divi's Laboratories Ltd
—7.61%
3
Divi's Laboratories Ltd
—7.40%
4
Max Healthcare Institute Ltd Ordinary Shares
—7.14%
5
Dr Reddy's Laboratories Ltd
—7.12%
4
Max Healthcare Institute Ltd Ordinary Shares
—6.92%
5
Cipla Ltd
—6.76%
6
Cipla Ltd
—6.72%
6
Dr Reddy's Laboratories Ltd
—5.92%
7
J.B. Chemicals & Pharmaceuticals Ltd
—4.91%
7
J.B. Chemicals & Pharmaceuticals Ltd
—4.57%
8
Lupin Ltd
—3.81%

Fundamentals (vs category)

Portfolio-weighted ratios, compared with the category average.

MetricFundCategory avgDiff

P/E ratio38.9641.09-2.13
P/B ratio5.525.83-0.31
Price / Sales5.405.71-0.31
Price / Cash Flow29.7230.54-0.82
Dividend yield0.78%0.63%+0.15
Return on equity (ROE)16.42%16.57%-0.15

Risk metrics

Standard deviation, Sharpe, Sortino, Beta — all vs category average.

Metric1Y3Y5YCat 1YCat 3YCat 5Y

Standard deviation
Volatility — lower means steadier returns.
———14.9216.2915.44
Sharpe ratio
Risk-adjusted return — higher is better.
———0.480.980.58
Sortino ratio
Like Sharpe but only counts downside volatility.
———0.831.710.94
Beta
1 = moves with the market. <1 = less volatile.
———0.940.950.94

Peers in Sectoral / Thematic

Other schemes in the same SEBI category, ranked by AUM.

Peer fundAUM1Y3Y CAGRExpense

Peers in same SEBI category, ranked by AUM. Compare any →

Available plans & options

PlanOptionFull nameISIN

Click a plan to see its NAV and chart above. Direct plans have lower expense ratios than Regular — same portfolio, more of the return stays with you.

NEW

See your SIP through Indian market history

Pick a fund and a start year — get a 60-second cinematic replay of every crash, boom, and headline with your money in it. Real NAV data, no “assumed 12%” lies.

Try Wealth Time Machine

AI · Free

Find what's really inside your funds

Upload your CAS PDF — get instant stock concentration, hidden fund overlap, sector risk, and 3 key insights, written by AI in plain English.

Run Portfolio X-Ray